![](/img/cover-not-exists.png)
Efficacy and tolerability of intranasal fentanyl spray 50 to 200 μg for breakthrough pain in patients with cancer: A phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period
Hans Georg Kress, Anna Orońska, Zbigniew Kaczmarek, Stein Kaasa, Torben Colberg, Thomas NolteVolume:
31
Year:
2009
Language:
english
Pages:
15
DOI:
10.1016/j.clinthera.2009.05.022
File:
PDF, 1.88 MB
english, 2009